Virtus ETF Advisers’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-115,018
| Closed | -$294K | – | 454 |
|
|
2024
Q4 | $294K | Buy |
115,018
+58,911
| +105% | +$151K | 0.12% | 248 |
|
|
2024
Q3 | $209K | Hold |
56,107
| – | – | 0.1% | 248 |
|
|
2024
Q2 | $355K | Buy |
56,107
+34,817
| +164% | +$220K | 0.17% | 194 |
|
|
2024
Q1 | $114K | Sell |
21,290
-1,457
| -6% | -$7.82K | 0.06% | 350 |
|
|
2023
Q4 | $114K | Sell |
22,747
-11,714
| -34% | -$58.8K | 0.07% | 324 |
|
|
2023
Q3 | $58.2K | Sell |
34,461
-3,427
| -9% | -$5.79K | 0.04% | 406 |
|
|
2023
Q2 | $105K | Buy |
37,888
+22,879
| +152% | +$63.6K | 0.06% | 354 |
|
|
2023
Q1 | $27.3K | Sell |
15,009
-5,773
| -28% | -$10.5K | 0.02% | 440 |
|
|
2022
Q4 | $105K | Sell |
20,782
-14,266
| -41% | -$72.3K | 0.06% | 438 |
|
|
2022
Q3 | $174K | Buy |
35,048
+249
| +0.7% | +$1.24K | 0.07% | 332 |
|
|
2022
Q2 | $129K | Buy |
34,799
+7,456
| +27% | +$27.6K | 0.05% | 353 |
|
|
2022
Q1 | $153K | Sell |
27,343
-1,626
| -6% | -$9.1K | 0.07% | 225 |
|
|
2021
Q4 | $176K | Buy |
28,969
+14,725
| +103% | +$89.5K | 0.07% | 260 |
|
|
2021
Q3 | $139K | Sell |
14,244
-738
| -5% | -$7.2K | 0.06% | 354 |
|
|
2021
Q2 | $214K | Sell |
14,982
-10,868
| -42% | -$155K | 0.09% | 292 |
|
|
2021
Q1 | $614K | Buy |
25,850
+462
| +2% | +$11K | 0.26% | 120 |
|
|
2020
Q4 | $338K | Buy |
+25,388
| New | +$338K | 0.14% | 178 |
|
|
2016
Q4 | – | Sell |
-37,895
| Closed | -$295K | – | 184 |
|
|
2016
Q3 | $295K | Hold |
37,895
| – | – | 0.14% | 101 |
|
|
2016
Q2 | $236K | Buy |
37,895
+23,332
| +160% | +$145K | 0.18% | 108 |
|
|
2016
Q1 | $120K | Buy |
+14,563
| New | +$120K | 0.17% | 137 |
|